KELLIE HOPKINS: Open Payments
NPI 1952709099 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 22 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $773 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $168 |
| Novo Nordisk Inc | 5 | $94 |
| Exact Sciences Corporation | 3 | $58 |
| Lilly USA, LLC | 2 | $43 |
| Globus Medical, Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $15 |
Products named: QULIPTA, MOUNJARO, The Cologuard Plus Collection Kit, Senza, SHINGRIX, UBRELVY, Ozempic, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
